Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on 4D Molecular Therapeutics (FDMT – Research ...

The department of Ophthalmology at Father Muller Medical College (FMMC), under the aegis of SKOS and ALCON, successfully ...

Alcon Inc. ALC gains on strong market share gains. The company’s broad pipeline and focus on research and innovation are ...

Alcon (ALC) announced the U.S. launch of SYSTANE PRO Preservative-Free PF as the latest over-the-counter eye drop in the company’s dry eye ...

Elucid, an AI medical technology company focused on providing physicians with a more precise view of atherosclerosis to drive patient-specific therapeutic decisions, has added several senior members ...

Alcon announced the US launch of SYSTANE PRO Preservative-Free (PF) as part of the company’s dry eye products. The ...

Full Year 2024 Results Key Financial Results Revenue: US$9.91b (up 4.8% from FY 2023). Net ...

Alcon, Inc. ALC delivered fourth-quarter 2024 core earnings per share (EPS) of 72 cents, up 2.9% from the year-ago quarter’s ...

European stocks are expected to open in mixed territory Tuesday as a lukewarm mood pervades global markets. The U.K.'s FTSE 100 index is expected to open unchanged at 8,637, Germany's DAX down 29 ...

A high ranking state official makes a cameo in our interview with a tribal behavioral health expert at the Roundhouse.

The Dry Eye Products market share report from The Insight Partners provides a comprehensive analysis of the growing dry eye products market, highlighting trends, innovations, and key growth ...

GLP-1 RAs show protective effects against primary open-angle glaucoma and ocular hypertension, surpassing alternative weight ...